Updated Jul 16, 2026
Glucksmann Alexandra has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Alexandra Glucksmann (alternatively presented as Alexandra Glucksmann; name variations may include 'Alexandra G. Glucksmann' or 'Glucksmann, Alexandra'). She is listed in connection with REGENXBIO Inc. in the most recent SEC filing dated 2026-06-02. The provided context does not specify her exact role (e.g., director, officer) at the company. REGENXBIO Inc. is a biotechnology company focused on gene therapy and NAV Technology. Given only the SEC context, this biography notes her association with Regenxbio without detailing a specific position or accomplishments.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | RGNX | REGENXBIO Inc. | A — Grant or award | 9.8K | $0.00 |
Alexandra Glucksmann (alternatively presented as Alexandra Glucksmann; name variations may include 'Alexandra G. Glucksmann' or 'Glucksmann, Alexandra'). She is listed in connection with REGENXBIO Inc. in the most recent SEC filing dated 2026-06-02. The provided context does not specify her exact role (e.g., director, officer) at the company. REGENXBIO Inc. is a biotechnology c…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Glucksmann Alexandra profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.